Siji Antiviral Mixture Protects against CA16 Induced Brain Injury through Inhibiting PERK/STAT3/NF-κB Pathway

Table 1

Summary of morbidity and mortality of mice infected with CA16 at different treatments.

Groups	Total no.	No. of mice exhibiting symptoms			No. of deaths
		Reduced mobility	Limb weakness	Paralysis
Control	10	0	0	0	0
Model	10	10(100%)	10(100%)	6(60%)	6(60%)
SAM(0.8g/kg)	10	10(100%)	9(90%)	4(40%)	6(60%)
SAM(1.6g/kg)	10	8(80%)	7(70%)	3(30%)	4(40%)
SAM(3.2g/kg)	10	7(70%)	5(50%)	1(10%)	3(30%)
RBV(0.01g/kg)	10	7(70%)	4(40%)	1(10%)	2(20%)